Archive page of posts in this category or categories:

The following posts are in no particular order. They are purposely randomized.

RSI News

Willhite receives prestigious SOT award

Calvin C. Willhite, an Associate Expert with Risk Sciences International working on a range of toxicological risk issues, was just announced as the recipient of the prestigious 2021 Arnold Lehman Award presented annually by the Society of Toxicology for outstanding contributions to evidence-based toxicology to improve public health. Dr. Willhite specializes in human health risk assessments for man-made…

Read More
RSI News

RSI contributes to newly published book on Blood Safety.

Written by experts in the field, Blood Safety: A Guide to Monitoring and Responding to Potential New Threats offers a concise yet comprehensive overview on critical issues in monitoring and responding to new microbial threats to blood safety.  The Book was edited by Hua Shan and Roger Dodd and recently published by Springer. RSI’s Anne Wiles, is lead author for…

Read More
RSI News

RSI receives National Defence funding

RSI is pleased to be the recipient of funding through the DND IDEaS COVID-19 Challenge. Under the supervision of Emma Hartnett, RSI will be developing a risk-based tool to support public health emergency response planning for COVID-19, and other infectious disease and mass casualty emergencies in the future. The safety and well-being of Canadians are…

Read More
RSI News

QuarterWatch analyzes MedWatch Reports

This issue of QuarterWatch analyzes MedWatch Reports from the third quarter of 2015. This issue identifies major differences in reports of cancer associated with drugs for psoriasis, a common skin disorder affecting an estimated 7.5 million people. While corticosteroid and other topical drugs are sufficient for many cases, potent immunosuppressant drugs are used in increasing…

Read More
RSI News

Dr. Mattison chairs NAM report

Compounded medications prepared by pharmacists or physicians have been used extensively throughout history as a mainstay of therapeutics.  Over the past half-century – with the increasing focus on evidence based treatment the use of compounded medications substantially decreased.  However, in some therapeutic areas, such as menopause, use of compounded medications continues.  The continuation of use…

Read More
RSI News

RSI Chairs Joint FAO/WHO Expert Meeting on Microbiological Risk Assessment (JEMRA)

RSI’s Dr. Emma Hartnett chaired the recent Joint FAO/WHO Expert Meeting on Microbiological Risk Assessment (JEMRA). The focus of the week-long event held March 11 to 15, 2019, was the update and consolidation of technical guidance documents to allow for a more current and coordinated approach to assessing microbiological hazards in food. For further information…

Read More
RSI News

RSI launches Global Risk Census

Risk Sciences International has launched The Global Risk Census. The goal of the Census is to provide insights into important risks that need to be confronted now and in the future. These insights will be of great value to decision-makers, policy-makers and indeed to all stakeholders affected by a myriad of local, regional or global…

Read More
RSI News

RSI paper on Manganese PBPK selected as a top 2017 paper

Each year the Society of Toxicology, Biological Modeling Specialty Section (BMSS) does a literature search to identify outstanding modeling papers in the field of toxicology. The PubMed search identified well over 300 papers for drugs and chemicals.  The list was reduced to approximately 60-70 in the general field of toxicology, and again reduced to 30+…

Read More
RSI News

RSI launches game-changing climate app

RSI launched the Climate Change Hazards Information Portal (CCHIP).

Read More
RSI News

Country Foods Forum

Leading up to February 11 and 12, 2020, Risk Sciences International had the privilege of assisting Health Canada in its organization of the Country Foods Forum. The event attracted a number of experts in country foods risk assessment from across Canada. Participants and speakers represented a broad cross section of stakeholders ranging from scientists to…

Read More